Clinical trial data on weight regain The STEP-10 extension trial revealed that participants who stopped semaglutide regained over 40% of their lost weight within just 28 weeks
Pediatric obesity treatment focuses heavily on family-based lifestyle changes, with medication acting as a support to prevent long-term health complications like early-onset Type 2 diabetes
Retatrutide has been evaluated in registered clinical studies, but those programs concern the developers investigational drug and controlled trial material
It is one of the most challenging forms of hyperpigmentation to treat because it is driven by multiple intersecting factors: hormones, chronic inflammation, heat, and UV exposure, often simultaneously
Menekan produksi glukagon, yaitu hormon yang biasanya meningkatkan kadar gula darah
Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective